Federal award (BPA CALL, fiscal year 2024)
Recipient: CERILLIANT CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-09-03 to 2025-09-30
Current total value of award: $21685.45
Description: DRUG STANDARDS TO BE USED IN SCREENING AND ANALYSIS TESTING FOR SUSPECTED DRUG USE IN SERVICE MEMBER BLOOD, URINE AND/OR TISSUE TESTING.